Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinglei Qu

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Cancer Research|December 12, 2022
TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancerMinghui Zhang, Bowen Yang, Lingyun Zhang, et al.
Translational Oncology|March 2, 2018
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer CellsYu Cheng, Yongxi Song, Jinglei Qu, et al.
Iscience|June 30, 2026
Dual modal pathomics model for colorectal cancer early recurrence prediction and mutation landscape analysisWenyu Luo, Runze Liu, Xiaomei Yang, et al.
BMC Cancer|June 27, 2018
MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinomaCe Li, Qian Dong, Xiaofang Che, et al.
Oncology Reports|July 18, 2018
Caveolin‑1 enhances RANKL‑induced gastric cancer cell migrationYan Wang, Yongxi Song, Xiaofang Che, et al.
Genes & Diseases|May 7, 2025
Genetic feature diversity of <i>KRAS</i>-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosisRuichuan Shi, Yu Cheng, Jin Wang, et al.
Cancer Medicine|April 4, 2023
Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1Chang Liu, Bo Jin, Yunpeng Liu, et al.
Frontiers in Oncology|May 11, 2023
Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trialJinglei Qu, Xin He, Ying Luo, et al.
Cancer Immunology Research|June 17, 2017
A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric CancerTi Wen, Zhenning Wang, Yi Li, et al.
Frontiers in Immunology|December 16, 2024
A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center studyNa Song, Yuee Teng, Jing Shi, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Cancer Research|December 12, 2022
TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancerMinghui Zhang, Bowen Yang, Lingyun Zhang, et al.
Translational Oncology|March 2, 2018
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer CellsYu Cheng, Yongxi Song, Jinglei Qu, et al.
Iscience|June 30, 2026
Dual modal pathomics model for colorectal cancer early recurrence prediction and mutation landscape analysisWenyu Luo, Runze Liu, Xiaomei Yang, et al.
BMC Cancer|June 27, 2018
MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinomaCe Li, Qian Dong, Xiaofang Che, et al.
Oncology Reports|July 18, 2018
Caveolin‑1 enhances RANKL‑induced gastric cancer cell migrationYan Wang, Yongxi Song, Xiaofang Che, et al.
Genes & Diseases|May 7, 2025
Genetic feature diversity of <i>KRAS</i>-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosisRuichuan Shi, Yu Cheng, Jin Wang, et al.
Cancer Medicine|April 4, 2023
Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1Chang Liu, Bo Jin, Yunpeng Liu, et al.
Frontiers in Oncology|May 11, 2023
Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trialJinglei Qu, Xin He, Ying Luo, et al.
Cancer Immunology Research|June 17, 2017
A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric CancerTi Wen, Zhenning Wang, Yi Li, et al.
Frontiers in Immunology|December 16, 2024
A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center studyNa Song, Yuee Teng, Jing Shi, et al.
Pageof 6